Correlation Between Unicycive Therapeutics and Lixte Biotechnology
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Unicycive Therapeutics and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Lixte Biotechnology.
Diversification Opportunities for Unicycive Therapeutics and Lixte Biotechnology
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Lixte is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Lixte Biotechnology go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Lixte Biotechnology
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.34 times more return on investment than Lixte Biotechnology. However, Unicycive Therapeutics is 2.96 times less risky than Lixte Biotechnology. It trades about 0.32 of its potential returns per unit of risk. Lixte Biotechnology Holdings is currently generating about 0.03 per unit of risk. If you would invest 48.00 in Unicycive Therapeutics on September 5, 2024 and sell it today you would earn a total of 23.00 from holding Unicycive Therapeutics or generate 47.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Lixte Biotechnology Holdings
Performance |
| Timeline |
| Unicycive Therapeutics |
| Lixte Biotechnology |
Unicycive Therapeutics and Lixte Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Lixte Biotechnology
The main advantage of trading using opposite Unicycive Therapeutics and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Lixte Biotechnology vs. Candel Therapeutics | Lixte Biotechnology vs. Cingulate Warrants | Lixte Biotechnology vs. Unicycive Therapeutics | Lixte Biotechnology vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |